样式: 排序: IF: - GO 导出 标记为已读
-
Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-18 Asif A. Hitawala, Harish Gopalakrishna, Maria Mironova, Alicia A. Livinski, Elizabeth C. Wright, Tacy Downing, Seiji Ito, Stacy D. Fisher, Ari M. Cedars, Anitha S. John, Theo Heller
-
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-18 Antonio De Vincentis, Federica Tavaglione, Shinichi Namba, Masahiro Kanai, Yukinori Okada, Yoichiro Kamatani, Samantha Maurotti, Claudio Pedone, Raffaele Antonelli Incalzi, Luca Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci
-
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-14 Nina Dominik, Bernhard Scheiner, Alberto Zanetto, Lorenz Balcar, Georg Semmler, Elena Campello, Michael Schwarz, Rafael Paternostro, Benedikt Simbrunner, Benedikt S. Hofer, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Peter Quehenberger, Paolo Simioni, Thomas Reiberger, Mattias Mandorfer
-
Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-13 Carolina Ramirez‐Cadiz, Hanna Blaney, Natalia Kubanek, Luis Antonio Díaz, Rohit Loomba, Lubomir Skladany, Juan Pablo Arab
-
Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding—the promise, controversies and future directions. Author's reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-10 Sagnik Biswas, Manas Vaishnav, Shalimar
This article is linked to Vaishnav et al papers. To view these articles, visit https://doi.org/10.1111/apt.17868 and https://doi.org/10.1111/apt.17882
-
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-10 Amanda Ricciuto, Kuan Liu, Wael El-Matary, Mansi Amin, Achiya Z. Amir, Madeleine Aumar, Marcus Auth, Matthew D. Di Guglielmo, Eleonora Druve Tavares Fagundes, Alexandre Rodrigues Ferreira, Katryn N. Furuya, Nitika Gupta, Stephen Guthery, Simon P. Horslen, Kyle Jensen, Binita M. Kamath, Nanda Kerkar, B. G. P. Koot, Trevor J. Laborda, Christine K. Lee, Kathleen M. Loomes, Cara Mack, Mercedes Martinez
-
Applying Lyon consensus criteria in the work-up of patients with extra-oesophageal symptoms – A multicentre retrospective study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-06 Francesco Calabrese, Andrea Pasta, Giorgia Bodini, Manuele Furnari, Patrizia Zentilin, Edoardo G. Giannini, Daria Maniero, Domenico Della Casa, Giovanni Cataudella, Marzio Frazzoni, Roberto Penagini, Arsiè Elena, Nicola de Bortoli, Pierfrancesco Visaggi, Vincenzo Savarino, Edoardo Savarino, Elisa Marabotto
-
Development and validation of a brain fog scale for coeliac disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-06 Simon R. Knowles, Pragalathan Apputhurai, Jason A. Tye-Din
-
Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction‐associated steatotic liver disease—authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Nipun Verma, Arka De, Ajay Duseja
LINKED CONTENTThis article is linked to Verma et al papers. To view these articles, visit https://doi.org/10.1111/apt.17891 and https://doi.org/10.1111/apt.17902
-
Editorial: Gastrointestinal symptoms—A world of differences Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Kevin W. Olden
LINKED CONTENTThis article is linked to Palsson et al paper. To view this article, visit https://doi.org/10.1111/apt.17894
-
Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B can increase body weight Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Youwen Tan, Sainan Zheng
LINKED CONTENTThis article is linked to Ogawa et al papers. To view these articles, visit https://doi.org/10.1111/apt.17107 and https://doi.org/10.1111/apt.17910
-
Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Haibo Jing, Lin Lin, Juan Xu, Huifeng Zhang, Lin Cao, Yaofu Fan
LINKED CONTENTThis article is linked to Martini et al papers. To view these articles, visit https://doi.org/10.1111/apt.17804 and https://doi.org/10.1111/apt.17916
-
Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding ‐ the promise, controversies and future directions Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Yu Jun Wong, Juan G. Abraldes
LINKED CONTENTThis article is linked to Vaishnav et al papers. To view these articles, visit https://doi.org/10.1111/apt.17868 and https://doi.org/10.1111/apt.17893
-
Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B can increase body weight—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Eiichi Ogawa
LINKED CONTENTThis article is linked to Ogawa et al papers. To view these articles, visit https://doi.org/10.1111/apt.17107 and https://doi.org/10.1111/apt.17896
-
Editorial: Corticosteroids for severe checkpoint inhibitor‐induced liver injury—Not one size fits all? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Morven Cunningham
LINKED CONTENTThis article is linked to Riveiro‐Barciela et al paper. To view this article, visit https://doi.org/10.1111/apt.17898
-
Editorial: The tsunami of steatotic liver disease in India, the Asia‐Pacific region and the world—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Manya Prasad, Tushar Prabhakar, Shiv Kumar Sarin
LINKED CONTENTThis article is linked to Prabhakar et al papers. To view these articles, visit https://doi.org/10.1111/apt.17892 and https://doi.org/10.1111/apt.17903
-
Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction‐associated steatotic liver disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Richie Manikat, Aijaz Ahmed, Donghee Kim
LINKED CONTENTThis article is linked to Verma et al papers. To view these articles, visit https://doi.org/10.1111/apt.17891 and https://doi.org/10.1111/apt.17913
-
Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Andrea Martini, Patrizia Pontisso
LINKED CONTENTThis article is linked to Martini et al papers. To view these articles, visit https://doi.org/10.1111/apt.17804 and https://doi.org/10.1111/apt.17901
-
Editorial: The tsunami of steatotic liver disease in India, the Asia‐Pacific region and the world Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Abdel‐Aziz Shaheen, Mayur Brahmania
LINKED CONTENTThis article is linked to Prabhakar et al papers. To view these articles, visit https://doi.org/10.1111/apt.17892 and https://doi.org/10.1111/apt.17921
-
Editorial: Liver elastography for chronic hepatitis D—the end of liver biopsy? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 María Buti, Adriana Palom, Mar Riveiro‐Barciela
LINKED CONTENTThis article is linked to Sandmann et al paper. To view this article, visit https://doi.org/10.1111/apt.17878
-
-
Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: A randomised, controlled proof‐of‐concept study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Angelo Armandi, Helena Bespaljko, Alexander Mang, Yvonne Huber, Maurice Michel, Christian Labenz, Peter R. Galle, Manjusha Neerukonda, Elisabetta Bugianesi, Detlef Schuppan, Jörn M. Schattenberg
-
Prevalence and risk factors of metabolic dysfunction‐associated steatotic liver disease in south Central Uganda: A cross‐sectional survey Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-09 Rocio Enriquez, Mahmoud Homsi, Robert Ssekubugu, Dorean Nabukalu, Zangin Zeebari, Gaetano Marrone, Bruna Gigante, Larry W. Chang, Steven J. Reynolds, Fred Nalugoda, Anna Mia Ekström, Hannes Hagström, Helena Nordenstedt
-
Review article: Pathogenesis of MASLD and MASH – role of insulin resistance and lipotoxicity Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-07 Shalini K. Bansal, Meena B. Bansal
-
Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study) Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-06 María José García, Sabino Riestra, Aurelien Amiot, Mette Julsgaard, Irene García de la Filia, Margalida Calafat, Mariam Aguas, Luisa de la Peña, Cristina Roig, Berta Caballol, María José Casanova, Klaudia Farkas, Trine Boysen, Luis Bujanda, Camila Cuarán, Daniela Dobru, Fotios Fousekis, Carla Jerusalén Gargallo‐Puyuelo, Edoardo Savarino, Xavier Calvet, José María Huguet, Limas Kupcinskas, Julia López‐Cardona
SummaryBackgroundThe advent of new therapeutic agents and the improvement of supporting care might change the management of acute severe ulcerative colitis (ASUC) and avoid colectomy.AimsTo evaluate the colectomy‐free survival and safety of a third‐line treatment in patients with ASUC refractory to intravenous steroids and who failed either infliximab or ciclosporin.MethodsMulticentre retrospective
-
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-04 Cathy Lu, Ryan Rosentreter, Maxime Delisle, Mattie White, Claire E. Parker, Zahra Premji, Stephanie R. Wilson, Mark E. Baker, Gauraang Bhatnagar, Jakob Begun, David H. Bruining, Robert Bryant, Britt Christensen, Brian G. Feagan, Joel G. Fletcher, Vipul Jairath, John Knudsen, Torsten Kucharzik, Christian Maaser, Giovanni Maconi, Kerri Novak, Jordi Rimola, Stuart A. Taylor, Rune Wilkens, Florian Rieder
-
Inflammatory bowel disease (IBD) patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomised controlled trial in Germany (IBDBIO‐ASSIST study) Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-02 Bernd Bokemeyer, Sandra Plachta‐Danielzik, Isa Maria Steiner, Daniela Pohlschneider, Eugen Urzica, Petra Hartmann, Jennifer Zemke, Ulrich Tappe, Stefan Schreiber, Nadine Steinkat, Jana Langbrandtner, Angelika Hüppe, Tom Stargardt
-
Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-01 Carl Eriksson, Jiangwei Sun, Matti Bryder, Gabriella Bröms, Åsa H. Everhov, Anders Forss, Tomas Jernberg, Jonas F. Ludvigsson, Ola Olén
-
CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-01 Hye Won Lee, Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Young‐Suk Lim, Henry Lik‐Yuen Chan, Sang Hoon Ahn, Grace Lai‐Hung Wong, Jonggi Choi
-
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-27 Marcus M. Mücke, María Hernández-Tejero, Wenyi Gu, Michael Kuhn, Malte Janz, Marisa I. Keller, Anthony Fullam, Laura Altepeter, Victoria T. Mücke, Fabian Finkelmeier, Katharina M. Schwarzkopf, Carla Cremonese, Peter-Merton Hunyady, Myriam W. Heilani, Frank Erhard Uschner, Robert Schierwagen, Maximilian J. Brol, Julia Fischer, Sabine Klein, Kai-Henrik Peiffer, Michael Hogardt, Saeed Shoaie, Minneke
-
Persistently high HBsAg levels during HBeAg‐seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-27 Hsin‐Che Lin, Wen‐Juei Jeng, Jessica Liu, Mei‐Hung Pan, Mei‐Hsuan Lee, Richard Batrla‐Utermann, Sheng‐Nan Lu, Chuen‐Fei Chen, Hwai‐I. Yang, Chien‐Jen Chen
-
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-27 Benedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger
-
Branched‐chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-26 Penelope Hey, Rudolf Hoermann, Marie Sinclair, Brooke Chapman, Adam Testro, Ross Apostolov, Peter Angus, Paul Gow
SummaryBackgroundSarcopenia is associated with adverse outcomes in cirrhosis. Branched‐chain amino acids (BCAA) target several pathways that lead to muscle loss in this population.AimsWe aimed to evaluate the impact of BCAA supplementation on sarcopenia measures in patients with cirrhosis.MethodsWe conducted a 12‐month double‐blinded, randomised, controlled trial of BCAA supplementation (30 g daily)
-
Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-24 Elsa L. S. A. van Liere, Nanne K. H. de Boer
LINKED CONTENTThis article is linked to Vasudevan et al papers. To view these articles, visit https://doi.org/10.1111/apt.17831 and https://doi.org/10.1111/apt.17895
-
Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease—authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-24 Abhinav Vasudevan, Danny Con, Daniel R. van Langenberg
LINKED CONTENTThis article is linked to Vasudevan et al papers. To view these articles, visit https://doi.org/10.1111/apt.17831 and https://doi.org/10.1111/apt.17876
-
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-24 Richie Manikat, Seung Up Kim, Aijaz Ahmed, Donghee Kim
LINKED CONTENTThis article is linked to Gawrieh et al papers. To view these articles, visit https://doi.org/10.1111/apt.17849 and https://doi.org/10.1111/apt.17886
-
Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels—authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-24 Naim Alkhouri, Leo Tseng, Kemal Balic, Hank Mansbach, Maya Margalit
LINKED CONTENTThis article is linked to Alkhouri et al papers. To view these articles, visit https://doi.org/10.1111/apt.17709 and https://doi.org/10.1111/apt.17881
-
-
Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-24 Eleni Geladari, Theodoros Alexopoulos, Larisa Vasilieva, Roxane Tenta, Meropi Kontogianni, Alexandra Alexopoulou
LINKED CONTENTThis article is linked to Alkhouri et al papers. To view these articles, visit https://doi.org/10.1111/apt.17709 and https://doi.org/10.1111/apt.17907
-
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-24 Samer Gawrieh, Mark Sulkowski, Naga Chalasani, Rohit Loomba
LINKED CONTENTThis article is linked to Gawrieh et al papers. To view these articles, visit https://doi.org/10.1111/apt.17849 and https://doi.org/10.1111/apt.17871
-
High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-23 Jun Sik Yoon, Ji Hoon Hong, Soo Young Park, Seung Up Kim, Hwi Young Kim, Ju Yeon Kim, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Han Ah Lee, Gi‐Ae Kim, Dong Hyun Sinn, Sung Jae Park, Youn Jae Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee
SummaryBackgroundProton pump inhibitors (PPI) are frequently used in patients with cirrhosis.AimsThis study aimed to determine whether PPI use is associated with the prognosis of cirrhotic patients.MethodsWe conducted a multicentre retrospective cohort study involving 1485 patients who had experienced hepatic encephalopathy (HE) from 7 referral centres in Korea. The primary outcome was overall survival
-
UK guideline on the transition and management of childhood liver diseases in adulthood Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-22 Deepak Joshi, Jeremy Nayagam, Lisa Clay, Jenny Yerlett, Lee Claridge, Jemma Day, James Ferguson, Paul Mckie, Roshni Vara, Henry Pargeter, Rachel Lockyer, Rebecca Jones, Michael Heneghan, Marianne Samyn
-
Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-19 Emily Nash, Amanda Nicoll, Nicholas Batt, Jacob George, Varan Perananthan, David Prince, Michael Wallace, Paul Gow, Karl Vaz, Shivakumar Chitturi, Joan Ericka Flores, Alicia Braund, Mark Bonnichsen, Stephen Riordan, Jeremy Humphris, Tuan Duong, Catriona McKenzie, Ken Liu, Simone I. Strasser
SummaryBackgroundReports of DILI due to herbal and dietary supplements have been increasing over time.AimsTo characterise clinical, laboratory and histopathological phenotypes and outcomes of drug‐induced liver injury (DILI) due to anabolic‐androgenic steroids (AAS), selective androgen receptor modulators (SARMs), and bodybuilding supplements (BBS) in Australia.MethodsRetrospective case series. Patients
-
Upper limit of normal ALT levels in health and metabolic diseases: Pooled analysis of 423,355 individuals with bootstrap modelling Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-19 Eunice X. Tan, Daniel Q. Huang, Natasha Tang Sook Yee, Zi Hui Wan, Sanjna N. Nerurkar, Justin Chua Ying Kai, Kang Shiong Goh, Cheng Han Ng, Mark Muthiah, Yu Zhou, Amanda Woodward, Michael H. Le, Yee Hui Yeo, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen
-
Meta‐analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-19 Mohammad Zamani, Shaghayegh Alizadeh‐Tabari, Mohammad Hassan Murad, Ashwin N. Ananthakrishnan, Reza Malekzadeh, Nicholas J. Talley
-
Editorial: How often can we get the right diagnosis after bone marrow transplant in patients with abnormal liver function tests? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-13 C. Gaume, C. Moluçon Chabrot, P. Chabrot, A. Abergel
This article is linked to Dezan et al papers. To view these articles, visit https://doi.org/10.1111/apt.17756 and https://doi.org/10.1111/apt.17870
-
Editorial: How often can we get the right diagnosis after bone marrow transplant in patients with abnormal liver function tests? Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-13 Maria Gabriela Fernandes Dezan, Lourianne Nascimento Cavalcante, Hugo Rodrigues Carvalho Silva, Alessandro de Moura Almeida, Luiz Henrique dos Santos de Assis, Tiago Thalles de Freitas, Marco Aurélio Salvino de Araújo, Helma Pinchemel Cotrim, Andre Castro Lyra
This article is linked to Dezan et al papers. To view these articles, visit https://doi.org/10.1111/apt.17756 and https://doi.org/10.1111/apt.17840
-
Editorial: Enhancing frailty assessment in liver transplantation candidates—The role of the Duke Activity Status Index in predicting mortality and guiding prehabilitation Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-13 Sara J. Harris, Jonathan G. Stine
This article is linked to Williams et al papers. To view these articles, visit https://doi.org/10.1111/apt.17834 and https://doi.org/10.1111/apt.17874
-
Editorial: Enhancing frailty assessment in liver transplantation candidates—The role of the Duke Activity Status Index (DASI) in predicting mortality and guiding prehabilitation. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-13 Matthew J. Armstrong, Felicity R. Williams
This article is linked to Williams et al papers. To view these articles, visit https://doi.org/10.1111/apt.17834 and https://doi.org/10.1111/apt.17860
-
Editorial: The prevalence and outcomes of perianal Crohn's disease across the treatment eras—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-13 Lorant Gonczi, Laszlo Lakatos, Akos Ilias, Peter L. Lakatos
This article is linked to Gonczi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17836 and https://doi.org/10.1111/apt.17861
-
Letter: The multifaceted role of Escherichia coli in influencing disorders of industrial populations Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-13 Maria Rosa Ingrosso, Antonio Gasbarrini, Giovanni Cammarota, Gianluca Ianiro
This article is linked to Faqerah et al papers. To view these articles, visit https://doi.org/10.1111/apt.17720 and https://doi.org/10.1111/apt.17883
-
Letter: The multifaceted role of Escherichia coli in influencing disorders of the industrial populations—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-13 Konstantinos Gerasimidis, Nojoud Faqerah, Daniel Walker
This article is linked to Faqerah et al papers. To view these articles, visit https://doi.org/10.1111/apt.17720 and https://doi.org/10.1111/apt.17865
-
Letter: Should ulcerative colitis be monitored more or less invasively? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-13 David Laharie
This article is linked to Lenfant et al papers. To view these articles, visit https://doi.org/10.1111/apt.17753 and https://doi.org/10.1111/apt.17887
-
Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-13 Matthias Lenfant, Bram Verstockt, João Sabino, Séverine Vermeire, Marc Ferrante
This article is linked to Lenfant et al papers. To view these articles, visit https://doi.org/10.1111/apt.17753 and https://doi.org/10.1111/apt.17873
-
Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment eras Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-13 Daniel Tassone, Imogen Hartley, Nik Sheng Ding
This article is linked to Gonczi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17836 and https://doi.org/10.1111/apt.17879
-
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-07 Mar Riveiro-Barciela, Ana Barreira-Díaz, María-Teresa Salcedo, Ana Callejo-Pérez, Eva Muñoz-Couselo, Patricia Iranzo, Carolina Ortiz-Velez, Susana Cedrés, Nely Díaz-Mejía, Juan Carlos Ruiz-Cobo, Rafael Morales, Juan Aguilar-Company, Ester Zamora, Mafalda Oliveira, María-Teresa Sanz-Martínez, Lluis Viladomiu, Mónica Martínez-Gallo, Enriqueta Felip, María Buti
-
High prevalence of MAFLD in general population: A large cross-sectional study calls for concerted public health action Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-06 Tushar Prabhakar, Manya Prasad, Guresh Kumar, Kanica Kaushal, Priyanka S. Shenoy, Shantanu Dubey, Shiv Kumar Sarin
-
Worldwide population prevalence and impact of sub-diagnostic gastrointestinal symptoms Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-04 Olafur S. Palsson, Jan Tack, Douglas A. Drossman, Boris Le Nevé, Laurent Quinquis, Rim Hassouna, Johannah Ruddy, Carolyn B. Morris, Ami D. Sperber, Shrikant I. Bangdiwala, Magnus Simrén
-
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease – The Gut and Obesity in Asia (GO-ASIA) Study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-01 Nipun Verma, Ajay Duseja, Manu Mehta, Arka De, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ruveena Bhavani Rajaram, Wah-Kheong Chan, Sanjiv Mahadeva, Ming-Hua Zheng, Wen-Yue Liu, Sombat Treeprasertsuk, Thaninee Prasoppokakorn, Satoru Kakizaki, Yosuke Seki, Kazunori Kasama, Phunchai Charatcharoenwitthaya, Phalath Sathirawich, Anand Kulkarni, Hery Djagat Purnomo, Lubna Kamani, Yeong Yeh Lee
-
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-02-01 Wen Hui Lim, Phoebe Tay, Cheng Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Muthiah, Eunice X. X. Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P. Lee, Philippe Mathurin, Rohit Loomba, Daniel Q. Huang